BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

249 related articles for article (PubMed ID: 17055226)

  • 1. Differential intracellular signalling induced by TGF-beta in rat adult hepatocytes and hepatoma cells: implications in liver carcinogenesis.
    Caja L; Ortiz C; Bertran E; Murillo MM; Miró-Obradors MJ; Palacios E; Fabregat I
    Cell Signal; 2007 Apr; 19(4):683-94. PubMed ID: 17055226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Involvement of EGF receptor and c-Src in the survival signals induced by TGF-beta1 in hepatocytes.
    Murillo MM; del Castillo G; Sánchez A; Fernández M; Fabregat I
    Oncogene; 2005 Jun; 24(28):4580-7. PubMed ID: 15856020
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Caveolin-1-dependent activation of the metalloprotease TACE/ADAM17 by TGF-β in hepatocytes requires activation of Src and the NADPH oxidase NOX1.
    Moreno-Càceres J; Mainez J; Mayoral R; Martín-Sanz P; Egea G; Fabregat I
    FEBS J; 2016 Apr; 283(7):1300-10. PubMed ID: 26815118
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Autocrine production of TGF-beta confers resistance to apoptosis after an epithelial-mesenchymal transition process in hepatocytes: Role of EGF receptor ligands.
    Del Castillo G; Murillo MM; Alvarez-Barrientos A; Bertran E; Fernández M; Sánchez A; Fabregat I
    Exp Cell Res; 2006 Sep; 312(15):2860-71. PubMed ID: 16828470
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Activation of NADPH oxidase by transforming growth factor-beta in hepatocytes mediates up-regulation of epidermal growth factor receptor ligands through a nuclear factor-kappaB-dependent mechanism.
    Murillo MM; Carmona-Cuenca I; Del Castillo G; Ortiz C; Roncero C; Sánchez A; Fernández M; Fabregat I
    Biochem J; 2007 Jul; 405(2):251-9. PubMed ID: 17407446
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Caveolin-1 is required for TGF-β-induced transactivation of the EGF receptor pathway in hepatocytes through the activation of the metalloprotease TACE/ADAM17.
    Moreno-Càceres J; Caja L; Mainez J; Mayoral R; Martín-Sanz P; Moreno-Vicente R; Del Pozo MÁ; Dooley S; Egea G; Fabregat I
    Cell Death Dis; 2014 Jul; 5(7):e1326. PubMed ID: 25032849
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The epithelial mesenchymal transition confers resistance to the apoptotic effects of transforming growth factor Beta in fetal rat hepatocytes.
    Valdés F; Alvarez AM; Locascio A; Vega S; Herrera B; Fernández M; Benito M; Nieto MA; Fabregat I
    Mol Cancer Res; 2002 Nov; 1(1):68-78. PubMed ID: 12496370
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The transforming growth factor-beta (TGF-β) mediates acquisition of a mesenchymal stem cell-like phenotype in human liver cells.
    Caja L; Bertran E; Campbell J; Fausto N; Fabregat I
    J Cell Physiol; 2011 May; 226(5):1214-23. PubMed ID: 20945437
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prostaglandin E2 upregulates EGF-stimulated signaling in mitogenic pathways involving Akt and ERK in hepatocytes.
    Dajani OF; Meisdalen K; Guren TK; Aasrum M; Tveteraas IH; Lilleby P; Thoresen GH; Sandnes D; Christoffersen T
    J Cell Physiol; 2008 Feb; 214(2):371-80. PubMed ID: 17654493
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidermal growth factor receptor signaling in hepatocellular carcinoma: inflammatory activation and a new intracellular regulatory mechanism.
    Berasain C; Nicou A; Garcia-Irigoyen O; Latasa MU; Urtasun R; Elizalde M; Salis F; Perugorría MJ; Prieto J; Recio JA; Corrales FJ; Avila MA
    Dig Dis; 2012; 30(5):524-31. PubMed ID: 23108309
    [TBL] [Abstract][Full Text] [Related]  

  • 11. HB-EGF release mediates glucose-induced activation of the epidermal growth factor receptor in mesangial cells.
    Uttarwar L; Peng F; Wu D; Kumar S; Gao B; Ingram AJ; Krepinsky JC
    Am J Physiol Renal Physiol; 2011 Apr; 300(4):F921-31. PubMed ID: 21289053
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transforming growth factor-beta activates both pro-apoptotic and survival signals in fetal rat hepatocytes.
    Valdés F; Murillo MM; Valverde AM; Herrera B; Sánchez A; Benito M; Fernández M; Fabregat I
    Exp Cell Res; 2004 Jan; 292(1):209-18. PubMed ID: 14720520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Inhibition of the EGF receptor blocks autocrine growth and increases the cytotoxic effects of doxorubicin in rat hepatoma cells: role of reactive oxygen species production and glutathione depletion.
    Ortiz C; Caja L; Sancho P; Bertran E; Fabregat I
    Biochem Pharmacol; 2008 May; 75(10):1935-45. PubMed ID: 18371937
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The inhibition of the epidermal growth factor (EGF) pathway enhances TGF-beta-induced apoptosis in rat hepatoma cells through inducing oxidative stress coincident with a change in the expression pattern of the NADPH oxidases (NOX) isoforms.
    Sancho P; Bertran E; Caja L; Carmona-Cuenca I; Murillo MM; Fabregat I
    Biochim Biophys Acta; 2009 Feb; 1793(2):253-63. PubMed ID: 18848961
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Upregulation of the NADPH oxidase NOX4 by TGF-beta in hepatocytes is required for its pro-apoptotic activity.
    Carmona-Cuenca I; Roncero C; Sancho P; Caja L; Fausto N; Fernández M; Fabregat I
    J Hepatol; 2008 Dec; 49(6):965-76. PubMed ID: 18845355
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Dissecting the effect of targeting the epidermal growth factor receptor on TGF-β-induced-apoptosis in human hepatocellular carcinoma cells.
    Caja L; Sancho P; Bertran E; Fabregat I
    J Hepatol; 2011 Aug; 55(2):351-8. PubMed ID: 21147185
    [TBL] [Abstract][Full Text] [Related]  

  • 17. EGFR is dispensable for c-Met-mediated proliferation and survival activities in mouse adult liver oval cells.
    Martínez-Palacián A; Del Castillo G; Herrera B; Fernández M; Roncero C; Fabregat I; Sánchez A
    Cell Signal; 2012 Feb; 24(2):505-513. PubMed ID: 22001397
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The level of caveolin-1 expression determines response to TGF-β as a tumour suppressor in hepatocellular carcinoma cells.
    Moreno-Càceres J; Caballero-Díaz D; Nwosu ZC; Meyer C; López-Luque J; Malfettone A; Lastra R; Serrano T; Ramos E; Dooley S; Fabregat I
    Cell Death Dis; 2017 Oct; 8(10):e3098. PubMed ID: 29022911
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transforming growth factor-beta induces epithelial to mesenchymal transition by down-regulation of claudin-1 expression and the fence function in adult rat hepatocytes.
    Kojima T; Takano K; Yamamoto T; Murata M; Son S; Imamura M; Yamaguchi H; Osanai M; Chiba H; Himi T; Sawada N
    Liver Int; 2008 Apr; 28(4):534-45. PubMed ID: 18031476
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidermal growth factor impairs the cytochrome C/caspase-3 apoptotic pathway induced by transforming growth factor beta in rat fetal hepatocytes via a phosphoinositide 3-kinase-dependent pathway.
    Fabregat I; Herrera B; Fernández M; Alvarez AM; Sánchez A; Roncero C; Ventura JJ; Valverde AM; Benito M
    Hepatology; 2000 Sep; 32(3):528-35. PubMed ID: 10960445
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.